Barrow, Hanley, Mewhinney & Strauss
HLF icon

Barrow, Hanley, Mewhinney & Strauss’s Herbalife HLF Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-838
Closed -$7.23K – 349
2025
Q1 		$7.23K Hold
838
– – ﹤0.01% 235
2024
Q4 		$5.61K Hold
838
– – ﹤0.01% 263
2024
Q3 		$6.03K Sell
838
-69
-8% -$635 ﹤0.01% 259
2024
Q2 		$9.42K Buy
907
+197
+28% +$1.97K ﹤0.01% 211
2024
Q1 		$7.13K Hold
710
– – ﹤0.01% 223
2023
Q4 		$10.8K Sell
710
-107
-13% -$1.48K ﹤0.01% 188
2023
Q3 		$11.4K Buy
817
+198
+32% +$2.99K ﹤0.01% 171
2023
Q2 		$8.2K Buy
+619
New +$8.42K ﹤0.01% 197
2018
Q3 		– Sell
-391
Closed -$21K – 415
2018
Q2 		$21K Sell
391
-315
-45% -$16.6K ﹤0.01% 350
2018
Q1 		$34K Hold
706
– – ﹤0.01% 360
2017
Q4 		$24K Hold
706
– – ﹤0.01% 384
2017
Q3 		$24K Hold
706
– – ﹤0.01% 393
2017
Q2 		$25K Hold
706
– – ﹤0.01% 393
2017
Q1 		$21K Buy
+706
New +$19.6K ﹤0.01% 398

Other funds holding HLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's HLF Position: Q2 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Herbalife (HLF) in Q2 2025, closing a stake of 838 shares — an estimated $7.23K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in HLF in Q1 2017 and held it in 14 quarters. The position peaked at $34K in Q1 2018. 210 funds tracked by Wall St. Rank hold HLF as of Q2 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Herbalife position as of Q2 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 838 Herbalife shares in Q2 2025, an estimated $7.23K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Herbalife in Q1 2017 and held it in 14 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Herbalife position peaked at $34K in Q1 2018.
  • 210 funds tracked by Wall St. Rank held Herbalife as of Q2 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.